LASIK for Diabetics: Eligibility & Healing Tips

Many people with well-controlled diabetes have elective eye surgery safely. The key is glycemic stability, absence of significant diabetic eye disease, and careful planning with both your surgeon and your diabetes care team.

Can diabetics get LASIK?

Yes, but eligibility depends on several measurable factors rather than a simple yes-or-no diagnosis. Diabetes affects nearly every step of the LASIK process: corneal nerve function, epithelial healing, tear production, and even how reliably pre-operative measurements predict outcomes. When blood glucose is well controlled and the eyes are free of active diabetic complications, outcomes are comparable to non-diabetic patients in most published studies.

A1C thresholds: what surgeons look for

Most refractive surgeons use hemoglobin A1C as a proxy for recent glycemic control. While there is no universally mandated cutoff, the following ranges reflect common clinical practice:

• A1C below 7%: Generally considered well controlled. Most surgeons are comfortable proceeding if other criteria are met.
• A1C 7% to 8%: A gray zone. Some surgeons will proceed with additional counseling about healing timelines; others prefer the patient to improve control first.
• A1C above 8%: Most surgeons will defer surgery and recommend optimizing blood glucose before scheduling. Healing is slower, infection risk is higher, and refractive measurements may be less stable because glucose fluctuations alter lens hydration and corneal curvature.

A single A1C reading is not enough. Surgeons want to see a trend of stability, typically two or more readings within range over the preceding six to twelve months. Patients whose A1C has recently dropped from 10% to 7% may still be asked to wait a few months to confirm the improvement is sustained and that refractive measurements are stable.

Diabetic retinopathy screening requirements

Before any elective eye procedure, diabetic patients need a dilated fundus examination to assess for:

• No diabetic retinopathy (NDR). The ideal scenario for LASIK candidacy. Proceed with standard evaluation.
• Mild non-proliferative diabetic retinopathy (mild NPDR). Some surgeons will still consider LASIK if the retinopathy is stable, the patient’s A1C is in range, and the retina specialist concurs. Close post-operative retinal monitoring is added to the follow-up schedule.
• Moderate to severe NPDR or proliferative diabetic retinopathy (PDR). LASIK is generally deferred. The priority shifts to retinal treatment (anti-VEGF injections, laser photocoagulation) before any elective corneal procedure.
• Diabetic macular edema (DME). An active contraindication for elective refractive surgery. DME must be treated and resolved before LASIK is considered.

Optical coherence tomography (OCT) of the macula is a standard part of the pre-operative workup for diabetic patients, even those with no visible retinopathy, because subclinical macular changes can affect visual outcomes.

Corneal and tear film considerations in diabetic patients

Diabetes affects the cornea in ways that are directly relevant to LASIK:

• Diabetic keratopathy. Reduced corneal sensitivity and impaired epithelial healing are common, especially in patients with peripheral neuropathy. This can delay the surface healing component of LASIK and increase the risk of persistent epithelial defects after PRK.
• Reduced tear production. Diabetic patients have higher rates of dry eye disease. A thorough tear film evaluation (Schirmer test, tear break-up time, meibography) is essential before surgery. Pre-operative dry eye treatment with artificial tears, cyclosporine or lifitegrast drops, and lid hygiene can improve both comfort and visual outcomes.
• Corneal nerve changes. Confocal microscopy studies show reduced corneal nerve fiber density in diabetic patients. Since LASIK further disrupts corneal nerves (to create the flap), the additive effect can worsen post-operative dryness. This is one reason some surgeons recommend PRK or SMILE for diabetic patients when feasible.

Healing timeline differences

Diabetic patients should expect a healing trajectory that is broadly similar to non-diabetic patients but potentially slower at each stage:

These are approximations. Patients with A1C consistently below 7% and no neuropathy may heal on the same timeline as non-diabetic patients. Those with borderline control or mild neuropathy may trend toward the longer end.

Post-operative blood glucose management

Surgery itself, even a brief outpatient procedure like LASIK, can cause a mild stress response that transiently raises blood glucose. More importantly, the post-operative period involves:

• Topical steroid drops (typically prednisolone or fluorometholone for one to four weeks). While the systemic absorption of eye drops is minimal, patients on tight insulin regimens should be aware that steroids can nudge glucose upward. Blood glucose monitoring should continue at the patient’s usual frequency during the drop taper.
• Reduced physical activity. Patients are advised to avoid strenuous exercise for a week or more. For patients who rely on exercise to manage blood glucose, this disruption should be anticipated with dietary or medication adjustments.
• Stress and sleep. Some patients experience anxiety or disrupted sleep around surgery, both of which can affect glucose. Planning ahead with the endocrinology or primary care team helps.

The single most important post-operative instruction for diabetic patients is: do not let blood glucose management lapse during recovery. Elevated glucose during the healing window directly impairs collagen remodeling and immune defense.

Complication rates for diabetic patients

Published literature shows that complication rates in well-controlled diabetic patients are only modestly elevated compared to the general population:

• Dry eye at 3 months: Approximately 30-40% of diabetic patients report bothersome dryness (versus 20-30% in the general LASIK population). By 12 months, rates converge.
• Epithelial healing delay: Roughly 5-8% of diabetic patients experience slower epithelial closure, compared to 1-3% overall. This is more relevant for PRK than LASIK.
• Enhancement rates: Some studies report modestly higher enhancement (touch-up) rates in diabetic patients (5-10% versus 3-7% in the general population), likely due to less predictable refractive stability.
• Infection: There is no strong evidence of significantly increased infectious keratitis in well-controlled diabetic LASIK patients, but the theoretical risk supports meticulous drop compliance and hygiene.

Patients with poorly controlled diabetes (A1C above 9%, active retinopathy, or significant neuropathy) face meaningfully higher risks and are generally not offered elective refractive surgery.

When another option makes more sense

LASIK is not the only path to reduced dependence on glasses. For diabetic patients who are not ideal LASIK candidates, alternatives include:

• PRK. Avoids the flap entirely, which can be preferable for patients with diabetic keratopathy. The longer healing period is a trade-off, and epithelial healing must be monitored closely.
• ICL (Implantable Collamer Lens). A good option for high myopia or when corneal considerations make surface ablation less ideal. ICL does not alter the cornea and is reversible. Diabetic patients still need retinal clearance.
• Refractive lens exchange (RLE). For diabetic patients over 50, especially those with early cataract changes, replacing the natural lens with a premium IOL can correct distance and sometimes near vision. This may be the most practical approach when cataract surgery is on the horizon anyway.

Building your care team

The best outcomes for diabetic patients come from coordinated care:

1. Endocrinologist or primary care provider. Documents A1C trend, medication stability, and systemic readiness. Provides a clearance letter.
2. Retina specialist (if needed). Confirms retinopathy status and clears the patient from a retinal standpoint.
3. Refractive surgeon. Performs corneal evaluation, dry eye workup, and determines the optimal procedure and timing.
4. Optometrist (co-management). Often handles routine post-operative visits and dry eye follow-up.

Questions to bring to your consultation

• What is the minimum A1C you require, and how many readings do you want to see?
• Have you reviewed my most recent dilated exam and OCT?
• Given my corneal nerve density and tear film, would you recommend PRK or SMILE over LASIK?
• What is your post-operative monitoring schedule for diabetic patients specifically?
• If I need an enhancement, how long do you wait before considering it?

Related guides

• LASIK and Autoimmune / Chronic Conditions
• Managing Dry Eye Before and After LASIK
• LASIK Recovery Timeline: Hour by Hour to Month 3
• LASIK Candidacy Checklist: How Surgeons Decide
• LASIK Risks, Complications, and How Surgeons Mitigate Them

Sources

• Halkiadakis I, et al. “Refractive surgery in diabetic patients: a review.” Eye and Vision. 2020.
• Shalchi Z, et al. “Safety of LASIK in patients with diabetes mellitus.” Journal of Cataract & Refractive Surgery. 2018.
• American Academy of Ophthalmology. “Diabetic Retinopathy Preferred Practice Pattern.” 2024.
• Gekka M, et al. “Corneal epithelial barrier function and wound healing in diabetic patients.” Cornea. 2017.
• Zhu X, et al. “Outcomes of LASIK and PRK in diabetic vs. non-diabetic patients: a meta-analysis.” BMC Ophthalmology. 2021.
• American Diabetes Association. “Standards of Care in Diabetes.” 2025.